نبذة مختصرة : Background: Systemic medicines for the treatment of acne (antibiotics, retinoids, oral contraceptives) frequently induce adverse events which result in dose reduction or treatment discontinuation and negatively influence treatment efficacy. Chronic application of topical agents may be associated with skin irritation and dermatitis. Thus, there is a constant need for new agents and therapeutic methods producing safe and effective treatment of this commonest skin disorder. Aim: To assess efficacy and tolerability of homeopathic medicine Loma Lux Acnemol in tablets. Materials and methods: 60 patients (age 18–35 years old) with mild and moderate acne were equally divided into two treatment and control groups. During 6 weeks, all patients received routine therapy of acne (sulphur preparations, vitamins, health-promoting therapies); in the treatment group, patients also received homeopathic medicine Loma Lux Acnemol (the dose depended on the body mass). Treatment efficacy criteria included severity of lesion hyperemia, regression of papular rash, absence of new elements and intensity of pain or burning sensation of the skin. Results: Adding Loma Lux Acnemol resulted in significantly better treatment efficacy compared to the routine therapy only: after 6 weeks, clinical improvement was registered in 16 (53.3%) and 6 (20%) patients in the treatment and control groups, respectively; clinical remission was induced in 5 (16.6%) and 7 (23.3%) patients, respectively; evident clinical improvement was absent in 9 (30%) and 12 (40%) cases, respectively. All patients treated with Loma Lux Acnemol reported good tolerability of the medicine; no adverse effects were observed. Conclusion: Homeopathic medicine Loma Lux Acnemol may be recommended for the treatment of mild and moderate acne in young patients. ; Актуальность. Препараты, применяемые в лечении акне системно (антибиотики, ретиноиды, оральные контрацептивы), нередко вызывают побочные реакции, что приводит к уменьшению дозировок или отмене препарата и отрицательно ...
Processing Request
No Comments.